Therefore, combining crizotinib with chemotherapy can accelerate the apoptosis of tumor cells, hinder the formation of tumors, inhibit the ALK and ROSI genes, and ensure a higher safety, which is easily accepted by clinical patients. Here, ALK is linked to neoplasm.